商用AI辅助系统对双参数MRI检出临床有意义前列腺癌的影响
这项单中心回顾性研究纳入52例经前列腺癌根治术证实的临床有意义前列腺癌患者,4名不同年资放射科医生在仅用T2WI和DWI的双参数模式下,比较医生单独、医生联合AI及AI单独三种阅片方式的诊断效能。结果显示AI辅助可提高病灶水平敏感度和AUC,低年资医生获益最明显,特异度未见统计学显著下降。
要点
- AI辅助在病灶水平提升3/4名阅片者敏感度,且未显著降低特异度
- 低年资医生病例水平敏感度从0.73提高至0.87,获益最明显
- AI单独判读特异度高(0.94)但敏感度低(0.34),不能替代医生独立诊断
核心结论
- 在这项前列腺切除术富集的小样本队列中,AI辅助与病灶水平区分度提高以及敏感度增加相关,低年资阅片者获益最明显。
- 该结果应被解读为概念验证/可行性数据,不能作为阅片者一致性改善或临床即刻推广的证据。
研究设计与样本
- 单中心回顾性研究,纳入2021至2023年52例经病理证实为临床有意义前列腺癌且术前行3.0T多参数MRI和根治性前列腺切除术的男性。
- 4名放射科医生(年资1至25年)仅使用双参数序列(T2WI和DWI)在医生单独、医生联合AI、AI单独三种情景下判读PI-RADS。
- 参考标准为根治性前列腺切除术病理结果;按病例(仅评估敏感度)和按病灶两种分析方式,以PI-RADS≥3为阳性。
关键影像表现/征象
- 本研究中病灶为前列腺MRI上的PI-RADS分类目标病灶,原文未提供具体病灶的T2WI、DWI或ADC信号特征描述。
诊断标准与关键数值
- 病例水平分析中,AI辅助仅使最低年资读者敏感度从0.73显著提高至0.87(p=0.046),其余读者点估计升高但无统计学意义。
- 病灶水平分析中,AI辅助显著提高3/4名读者的敏感度,并提高所有读者的AUC,p值范围0.002至0.027。
- 病灶水平读者内ΔAUC为+0.013至+0.037,所有95%CI均排除零;特异度变化均无统计学意义,所有p≥0.061。
- AI单独运行在病灶水平特异度为0.94,敏感度为0.34,病灶AUC为0.64,与最低年资读者最接近。
临床应用与阅片要点
- 低年资阅片者在双参数前列腺MRI判读中联合商用AI系统可较明显提高对临床有意义前列腺癌的病灶检出敏感度。
- AI单独特异度高但敏感度过低,临床上不适合作为独立诊断工具,应作为医生判读的决策支持。
- 本结果源自根治标本富集队列,应用于常规筛查或活检前人群时对阳性预测值和过度诊断风险需谨慎判断。
局限性
- 单中心、小样本且以前列腺切除术富集的设计,病例构成不能代表一般前列腺MRI检查人群。
- 结果仅能作为概念验证或可行性数据,不能说明阅片者间一致性改善或具有即时临床普适性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To determine whether QP-Prostate, a commercially available artificial intelligence (AI) decision-support system, improves Prostate Imaging Reporting and Data System (PI-RADS)-based detection of clinically significant prostate cancer (csPCa) using prostate MRI by readers with different levels of experience, without loss of specificity.
METHODS: This single-center retrospective study included 52 men with pathologically confirmed csPCa who underwent preoperative 3.0-T multiparametric magnetic resonance imaging (mpMRI) and radical prostatectomy between 2021 and 2023. To match AI inputs, four radiologists (1-25 years of experience) interpreted the PI-RADS findings using only biparametric components (T2WI and DWI) under three scenarios: reader-alone, reader + AI, and AI-alone. Per-case (evaluating sensitivity only) and per-lesion analyses were conducted, setting PI-RADS ≥ 3 as positive. The primary endpoint was the within-reader per-lesion AUC difference evaluated via DeLong's test with Holm adjustment; secondary metrics were assessed using DeLong and McNemar tests.
RESULTS: In the per-case (index-lesion) analysis, AI assistance significantly increased sensitivity only for the least-experienced reader, from 0.73 to 0.87 (p = 0.046), whereas higher point estimates for the other readers were not statistically significant. In the per-lesion analysis, AI assistance significantly improved sensitivity for 3/4 readers and increased AUC for all readers (p-values ranging 0.002-0.027; within-reader ΔAUC, +0.013 to + 0.037; all 95% CIs excluded zero), with no statistically significant change in specificity (all p ≥ 0.061). AI-alone showed high specificity (0.94) and low sensitivity (0.34) in the per-lesion analysis, with a per-lesion AUC (0.64) closest to that of the least-experienced reader.
CONCLUSION: In this small prostatectomy-enriched cohort, AI assistance was associated with improved lesion-level discrimination and increased sensitivity, with the greatest apparent benefit observed among less-experienced readers. These findings should be interpreted as proof-of-concept/feasibility data rather than as evidence of improved reader agreement or immediate clinical generalizability.
引用
- Higaki, Tamada, Takeuchi, et al. Impact of a commercial artificial intelligence decision-support system on biparametric MRI interpretation for detecting clinically significant prostate cancer: a retrospective single-center prostatectomy-validated multi-reader study across experience levels. Eur J Radiol. 2026. PMID: 42258918. doi:10.1016/j.ejrad.2026.112964
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。